The DIA Global Annual Meeting unites regulatory, industry, academic, and patient stakeholders to shape the future of healthcare product development. With a focus on global collaboration and innovation, the event covers regulatory science, clinical operations, medical affairs, and more—making it a must-attend for professionals across the life sciences.

The American Diabetes Association’s Scientific Sessions is a leading forum for cutting-edge research, clinical advancements, and innovation in diabetes care. With sessions covering basic science, translational research, and clinical practice, this event brings together healthcare professionals, researchers, and industry leaders to drive progress in the prevention and treatment of diabetes.

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most influential oncology conferences in the world. It highlights groundbreaking clinical research, emerging therapies, and advances in cancer care. A key event for sponsors, CROs, and life sciences professionals focused on oncology innovation and collaboration.

Fierce Biotech Week is a multi-day gathering of biotech innovators, investors, and industry leaders focused on the future of drug development and life science innovation. With a lineup of high-impact sessions, networking opportunities, and partner events, it offers a dynamic platform for collaboration across R&D, clinical strategy, and investment in biotech.

LSX World Congress Europe (LSX Europe) is a leading life sciences fundraising and investment event bringing together innovative early-stage companies with active global investors. The congress focuses on strategic one-on-one meetings and targeted networking designed to support capital raising and long-term partnerships.

Attendees include biotechnology, medical devices, diagnostics, and digital health companies—alongside venture capital firms, institutional investors, and strategic partners seeking new investment opportunities and syndication. Through its structured partnering format, LSX Europe facilitates meaningful conversations that translate into collaboration and successful fundraising.

RESI Europe is an investor-focused partnering conference connecting early-stage and emerging life sciences, healthcare, and medtech companies with global investors and strategic partners. The event emphasizes curated one-on-one meetings, company presentations, and networking opportunities designed to support capital formation and strategic growth.

RESI Europe brings together startups, venture capital firms, family offices, corporate venture groups, and industry leaders to explore innovation across biotechnology, medical devices, diagnostics, and digital health within the European life sciences ecosystem.

BIO-Europe Spring is a premier partnering conference connecting senior executives from biotechnology, pharmaceutical, and life sciences companies with investors, service providers, and strategic partners from around the world. The event focuses on early-stage innovation and growth-oriented companies, with an emphasis on business development, licensing, and investment opportunities.

Featuring structured one-on-one partnering meetings, company presentations, and targeted networking, BIO-Europe Spring provides a platform to explore emerging science, deal-making trends, and collaboration opportunities across the global life sciences ecosystem.

Join 400+ investors, biotech innovators, and biopharma executives at BIO’s premier investment and business development event. The BIG Summit focuses on capital formation, commercialization, reimbursement, and the evolving regulatory and policy landscape shaping life sciences.

Designed to foster strategic partnerships and drive growth, this two-day event delivers the insights and connections needed to support your next investment, acquisition, or breakthrough.

OCT West Coast 2026 brings together clinical trial professionals from pharmaceutical and biotechnology organizations to address the evolving operational, regulatory, and technological challenges of clinical development. The conference emphasizes collaboration, operational efficiency, innovation, and patient centricity across the clinical trial lifecycle.

The 2026 program features four dedicated content streams covering outsourcing and clinical operations, AI and technology transformation, patient centricity, and a new Biotech Strategy stream focused on drug development challenges and strategies from a small biotech perspective. Attendees will have the opportunity to exchange insights, explore targeted trial approaches, and connect with regional industry leaders.

Dates: January 12–14, 2026 (In Person) | January 20–21, 2026 (Virtual)
Location: Hilton San Francisco Union Square | Virtual (partneringONE)

Biotech Showcase is a dedicated investor conference connecting private and micro- to mid-cap biotechnology companies with global investors and biopharmaceutical executives. Now in its 18th edition, the event features 400+ carefully selected presenting companies spanning platform technologies, therapeutics, digital health, devices, and diagnostics.

Held annually during JP Morgan Healthcare Week, Biotech Showcase attracts investors representing over $400 billion in capital and strategic partners across the life sciences ecosystem. The conference is offered in a hybrid format, combining in-person presentations and partnering with virtual meetings hosted on the partneringONE platform.

The RESI Conference is a leading healthcare investment and partnering event bringing together early-stage life science investors, innovators, and industry experts. The conference features two days of in-person partnering and networking, followed by three days of virtual partnership meetings designed to facilitate meaningful connections.

This year’s RESI Conference is held concurrently with JP Morgan Healthcare Week, one of the largest and most influential healthcare investment gatherings globally, making it a pivotal week for biotech, medtech, and life sciences collaboration.